Deepti Shroff Karhade

1. A new WHO analysis finds one in six bacterial infections worldwide is now resistant to standard antibiotics. 2. Resistance rates are climbing between 5 and 15 percent annually, threatening the safety of surgery, chemotherapy, and intensive care worldwide. The World Health Organization has issued one of its starkest warnings to date about antimicrobial resistance, calling it a growing global crisis with deep clinical and economic consequences.

1. The FDA has cleared the first Alzheimer’s blood test for community use, marking a pivotal step toward earlier and less invasive diagnosis. 2. Roche and Lilly’s Elecsys pTau181 assay achieved a 97.9 percent negative predictive value and could screen over one million Americans within its first year. The FDA has approved a new blood test for Alzheimer’s disease, marking one of the most important advances in dementia diagnostics in decades.

The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. FDA approves Alzheimer’s blood test for use in primary care The FDA just cleared a new blood diagnostic for Alzheimer’s developed by Roche and Lilly to help screen patients earlier in primary care. The Elecsys pTau181 assay measures phosphorylated tau-181 in plasma and reached a 97.9 % negative predictive value in trials.